跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 21,665 条关于
“Gan & Lee Pharmaceutical”
全部
21,665
临床试验
7,031
药物
2,247
机构
2,372
资讯
10,015
去年
Gan & Lee Receives FDA Clearance for Phase II Trial of GZR18 in Obesity and Type 2 Diabetes
去年
Gan & Lee Pharmaceuticals Partners with Brazil to Localize Insulin Production in Landmark Agreement
去年
Gan & Lee's Novel Diabetes Drugs GZR18, GZR4, and GZR101 Achieve Positive Phase 2 Results
2年前
Gan & Lee's Once-Weekly Insulin GZR4 Shows Promising Phase I Results in Type 2 Diabetes
去年
Gan & Lee's Oral GLP-1 Agonist GZR18 Shows Promise in Phase 1 Trial
9个月前
Gan & Lee Pharmaceuticals Launches Phase 3 Trial for Once-Monthly GLP-1 Receptor Agonist Bofanglutide
去年
Gan & Lee's GZR18 Receives FDA IND Clearance for Phase 2 Obesity Trial
去年
Gan & Lee's Bofanglutide Shows Superior Efficacy to Semaglutide in Phase 2 Diabetes Trials
8个月前
Lupin Secures Exclusive Rights to Novel Fortnightly GLP-1 Receptor Agonist Bofanglutide for Indian Market
5个月前
Gan & Lee's Once-Weekly Insulin GZR4 Demonstrates Superior Efficacy in Phase 3 Trials
第 1 页,共 1002 页
上一页
下一页